<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="156376">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01886092</url>
  </required_header>
  <id_info>
    <org_study_id>H-1212-081-451</org_study_id>
    <secondary_id>SNUHT1</secondary_id>
    <nct_id>NCT01886092</nct_id>
  </id_info>
  <brief_title>Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus</brief_title>
  <acronym>rTMS</acronym>
  <official_title>Verification of the Usefulness of the Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Tinnitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>South Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Efficacy of different protocols of transcranial magnetic stimulation for the treatment of
      tinnitus
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex
      has an add-on effect for primary auditory cortex rTMS in improving tinnitus-related
      distress. The investigators aimed to investigate whether rTMS of the dorsolateral prefrontal
      cortex and primary auditory cortex are capable of reducing tinnitus loudness.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change of tinnitus severity as measured by the visual analogue scale (VAS)</measure>
    <time_frame>Change from Baseline in visual analogue scale at 3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Beck's Depression Inventory (BDI)</measure>
    <time_frame>Baseline, before and after each intervention, 1, 2 and 3 months after the first intervention</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory (STAI)</measure>
    <time_frame>Baseline, before and after each intervention, 1, 2 and 3 months after the first intervention</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh Sleep Quality Index (PSQI)</measure>
    <time_frame>Baseline, before and after each intervention, 1, 2 and 3 months after the first intervention</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tinnitus Handicap Inventory (THI)</measure>
    <time_frame>Baseline, day 3, day 7, day 14, 1, 2 and 3 months after the first intervention</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Tinnitus</condition>
  <arm_group>
    <arm_group_label>Active rTMS1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combined low frequency frontal and temporal repetitive transcranial magnetic stimulation of left primary auditory cortex and left dorsolateral prefrontal cortex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active rTMS2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Temporal low frequency repetitive transcranial magnetic stimulation of left primary auditory cortex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active rTMS3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Frontal low frequency repetitive transcranial magnetic stimulation of left dorsolateral prefrontal cortex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham rTMS4</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Combined low frequency frontal and temporal repetitive transcranial magnetic stimulation of left primary auditory cortex and left dorsolateral prefrontal cortex</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>repetitive transcranial magnetic stimulation (rTMS) 1</intervention_name>
    <description>repetitive transcranial magnetic stimulation (Figured 8-Coil Cool-B65): 1000 stimuli of 1Hz rTMS over the left dorsolateral prefrontal cortex (110% motor threshold) followed by 2000 stimuli of 1 Hz rTMS over the left primary auditory cortex (110% motor threshold), each consisting of 4 days of rTMS treatment. (20 subjects).</description>
    <arm_group_label>Active rTMS1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>repetitive transcranial magnetic stimulation (rTMS) 2</intervention_name>
    <description>repetitive transcranial magnetic stimulation (Figured 8-Coil MCF-B65): 3000 stimuli of 1 Hz rTMS over the left temporal cortex (110% motor threshold), each consisting of 4 days of rTMS treatment. (20 subjects)</description>
    <arm_group_label>Active rTMS2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>repetitive transcranial magnetic stimulation (rTMS) 3</intervention_name>
    <description>repetitive transcranial magnetic stimulation (Figured 8-Coil MCF-B65): 3000 stimuli of 1 Hz rTMS over the left dorsolateral prefrontal cortex (110% motor threshold) each consisting of 4 days of rTMS treatment. (20 subjects)</description>
    <arm_group_label>Active rTMS3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham repetitive transcranial magnetic stimulation (rTMS) 4</intervention_name>
    <description>Sham rTMS, applied with the same combination of parameters as active rTMS, except for the number of stimulations per session. (20 subjects)</description>
    <arm_group_label>Sham rTMS4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of chronic tinnitus

          -  Chronic subjective tinnitus for more than 6 months

          -  Subject is naive regarding rTMS

          -  Other concurrent treatments: A four-week washout from any other tinnitus   treatment
             or management program is required prior to entering this study

          -  Stable enough to complete this study per the opinion of the Study Physician

          -  No restrictions, provided the dosages have been in place for at least 3 months

          -  A three month washout from any other tinnitus treatment or management program is
             required prior to entering this study.

        Exclusion Criteria:

          -  Objective tinnitus or tinnitus with treatable cause

          -  Presence of intracranial or intraocular ferromagnetic materiel or particles

          -  Cardiac pacemaker or other electronic implants (including cochlear implant) Serious
             heart disease or other unstable major medical condition

          -  Personal history of central nervous system disorder, head injury, stroke or seizures

          -  Familial history of epilepsy

          -  Concomitant medication with antidepressants and antipsychotics

          -  Pregnant women

          -  Others known contraindications to rTMS or brain MRI
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Myung-Whan Suh, MD, ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tae-Soo Noh, BS</last_name>
    <phone>82-2-2072-2447</phone>
    <email>drmung@naver.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oh</last_name>
      <phone>02-2072-2114</phone>
    </contact>
    <investigator>
      <last_name>Lee, MD ph,D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 3, 2013</lastchanged_date>
  <firstreceived_date>June 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tinnitus</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
